findmyKOL
Clinical trialNCT06989567Not, yet, recruitingPhase 3Interventional

A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis

SponsorAsklepion Pharmaceuticals, LLCEnrollment120Sickle Cell Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Suvankar Majumdar, MD

    Center for Cancer and Blood Disorders, Children's National Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S National Hospital

    Washington D.C., District of Columbia, United States

  • University of Miami

    Coral Gables, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Johns Hopkins Hospital

    Baltimore, Maryland, United States

  • Children'S Hospital of Michigan

    Detroit, Michigan, United States

  • East Carolina (university of North Carolina)

    Greenville, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jul 2025
Primary completion
30 Jun 2027
Completion
30 Jun 2029
Last update posted
29 May 2025
Registered enrollment
120
Registry id
NCT06989567

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.